GSM: The Common, Fixable Reason Intimacy Starts to Hurt

Sexual Health, Part 1: GSM — The Common, Fixable Reason Intimacy Hurts

Sex used to feel good — and now it burns, or it’s simply too dry and uncomfortable to enjoy. Maybe you’ve quietly stopped altogether, assuming this is just what happens with age. I want you to hear this clearly: it isn’t inevitable, it isn’t your fault, and it is very treatable. Welcome to the first post in a series on sexual health in midlife.

We’re going to start with the single most common physical reason intimacy becomes uncomfortable after menopause — a condition called GSM. It’s wildly underdiagnosed, rarely discussed, and one of the most satisfying things in my practice to treat, because the relief is so real and so reliable.

What is GSM?

GSM stands for the genitourinary syndrome of menopause. It’s the modern name for what used to be called “vaginal atrophy,” and the newer term matters because the problem was never confined to the vagina — it affects the whole intimate and urinary system: the vulva, the vaginal opening (vestibule), the lower vagina, the clitoris, and the urethra. All of these tissues depend on estrogen, and all of them change when estrogen declines.

Why it happens

The tissues of your vulva, vagina, and urethra are rich in estrogen receptors. For all your reproductive years, estrogen kept them thick, elastic, well-lubricated, and richly supplied with blood. As estrogen falls through menopause, these tissues become thinner, drier, less elastic, and more fragile. Blood flow decreases. Natural lubrication drops. The vaginal pH rises, disrupting the protective bacterial ecosystem.

And here’s the part that makes GSM different from hot flashes: it’s progressive. Hot flashes usually fade with time. GSM, left untreated, tends to get worse — because the underlying estrogen deprivation continues. More than half of postmenopausal women are affected, yet only a small fraction are ever treated, largely because no one brings it up.

How GSM shows up — especially in your sexual health

  • Pain with intercourse (dyspareunia) — often burning, tearing, or rawness, especially at the vaginal opening.
  • Vaginal dryness and loss of natural lubrication with arousal.
  • Reduced sensation and slower, weaker sexual response — as blood flow to the clitoris and vulva declines.
  • Irritation, burning, or itching in daily life, not just during sex.
  • Urinary symptoms — urgency, frequency, discomfort with urination, and recurrent urinary tract infections.

Many women experience a quietly painful cascade: sex starts to hurt, so desire fades, so intimacy shrinks, so a part of their relationship and their sense of self quietly closes down — all from a physical problem that has a straightforward fix.

The most effective treatment: local topical estrogen

Here is the good news I most want you to take away. Low-dose topical estrogen — applied right where it’s needed, to the vulva, vestibule, lower vagina, the area around the urethra, and the clitoris — is the most effective treatment for GSM, and it works by actually restoring the tissue itself, not just masking symptoms.

With regular use, local estrogen rebuilds the thickness and elasticity of these tissues, restores blood flow, brings back natural lubrication, and re-establishes the healthy vaginal environment. For your sexual health specifically, that translates to real, noticeable improvements:

What local estrogen does for sexual health

  • Reduces and often eliminates pain with intercourse by restoring supple, resilient tissue.
  • Improves natural lubrication, so sex doesn’t feel dry or raw.
  • Improves sexual response and sensation by restoring blood flow to the clitoris and vulva.
  • Relieves daily discomfort — the burning and irritation that follow you around, not just during intimacy.

It comes in several convenient forms — creams, a small vaginal tablet or insert, or a ring that releases estrogen slowly — and applying it to the external tissues (vulva, vestibule, around the urethra and clitoris), not just internally, matters for addressing the full picture of sexual symptoms. It typically starts with a brief daily “loading” phase, then drops to twice-weekly maintenance, long term — because the tissue needs ongoing support, and symptoms return if it’s stopped.

It’s not just about comfort — treating GSM can be lifesaving

This is the part almost no one connects, and it’s genuinely important. By restoring the urinary and vaginal tissues, local estrogen substantially reduces recurrent urinary tract infections — and that has consequences far beyond discomfort, especially as women age.

Why fewer UTIs can mean a longer, safer life

In an older woman, a UTI is not always a minor nuisance. Consider the chain of events that recurrent UTIs can set off:

  • An untreated or ascending UTI can progress to a kidney infection and then to urosepsis — a bloodstream infection that is a leading cause of hospitalization and even death in older women.
  • The urinary urgency that comes with GSM and UTIs sends women rushing to the bathroom — and that rushing, especially at night, is a classic setup for a fall, a broken hip, and the cascade of decline that too often follows.

So treating GSM isn’t vanity or luxury — by cutting recurrent UTIs and calming urinary urgency, it can genuinely help prevent sepsis, falls, and fractures. It is preventive medicine in the truest sense.

“But I’ve had breast cancer — isn’t estrogen off-limits?”

This is the question I’m asked most anxiously, so let me be clear and reassuring. Low-dose vaginal (local) estrogen is a different matter entirely from systemic hormone therapy — and for most women with a history of breast cancer, it is considered reasonable and safe.

Because it works locally with only minimal absorption into the bloodstream, the evidence does not show that low-dose vaginal estrogen increases breast cancer recurrence. No woman — survivor or not — should have to accept a painful, uncomfortable intimate life and repeated UTIs as the price of survival. For most breast cancer survivors whose symptoms aren’t controlled by non-hormonal measures, local estrogen is a legitimate, life-enhancing option, best decided together with your oncologist. (Women on aromatase inhibitors are the one group warranting an extra, individualized conversation — but even that is a discussion, not an automatic no.)

Lubricants and moisturizers: helpful partners, but not the same thing

These are valuable tools, and I recommend them often — but it’s important to understand what they do and don’t do. They relieve symptoms; they don’t rebuild the tissue. Estrogen does something they cannot.

ProductWhen to use itWhat it does (and doesn’t)
LubricantsDuring intercourseReduce friction in the moment, making sex more comfortable. Water- or silicone-based are good choices. They work only while applied — a temporary aid, not a treatment.
MoisturizersRegularly (every few days), for maintenanceHydrate the tissue over time and ease daily dryness. Better for ongoing comfort than lubricants, but still do not restore the tissue’s thickness, elasticity, or blood flow.
Local estrogenOngoing, for the underlying problemActually restores the tissue — thickness, elasticity, lubrication, blood flow, and urinary protection. The only option that treats the cause, not just the symptom.

For many women, the best approach combines them: a moisturizer for daily comfort, a lubricant for intimacy, and local estrogen doing the deeper work of healing the tissue. Non-hormonal options also matter greatly for women who prefer them or can’t use estrogen — but when the goal is truly restoring the tissue, estrogen is in a class of its own.

The bottom line

  • GSM is common, progressive, and very treatable — declining estrogen thins and dries the vulva, vagina, urethra, and clitoris, making intimacy painful and daily life uncomfortable.
  • Local topical estrogen is the most effective treatment — applied to the vulva, vestibule, lower vagina, urethra, and clitoris, it restores the tissue itself: less pain, better lubrication, improved sexual response.
  • Treating GSM can be lifesaving — it reduces recurrent UTIs (which can lead to urosepsis) and calms the urgency that sends women rushing to the bathroom and risking falls and fractures.
  • Local estrogen is safe for most women — including most breast cancer survivors — because absorption into the bloodstream is minimal (with an individualized conversation for those on aromatase inhibitors).
  • Lubricants and moisturizers help but don’t heal — they ease symptoms; only estrogen restores the tissue. The best plans often combine all three.

You do not have to quietly give up on comfort or intimacy. GSM is one of the most fixable problems in midlife — and getting it treated can protect far more than your sex life.

If intimacy has become painful, or you’re caught in a cycle of UTIs, please know this is exactly the kind of thing worth being seen for — both to restore your comfort and to protect your long-term health. It’s one of my favorite conversations to have, because the relief is so real.

Coming next in this series…

We’ll continue exploring sexual health in midlife — desire, arousal, and the many threads (physical, hormonal, relational) that weave together into a satisfying intimate life. Stay tuned.

Selected References

  1. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause. 2020;27(9):976–992.
  2. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329(11):753–756.
  3. Tan-Kim J, et al. Vaginal estrogen for recurrent urinary tract infection prevention in hypoestrogenic women (~50% reduction). Am J Obstet Gynecol. 2023.
  4. ACOG Committee Opinion: The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. (Minimal systemic absorption; reasonable when non-hormonal options fail, with oncology input.)
  5. Beste ME, Kaunitz AM, et al. Vaginal estrogen use in breast cancer survivors: systematic review and meta-analysis (no significant increase in recurrence/mortality). Am J Obstet Gynecol. 2025.
  6. Lubricants and moisturizers for GSM: symptomatic relief without tissue restoration — comparative reviews. Climacteric / Maturitas.

This article is for educational purposes and reflects the state of the evidence at the time of writing; it is not a substitute for individualized medical advice. Any postmenopausal vaginal bleeding should be evaluated promptly. Decisions about vaginal estrogen — particularly for women with a history of breast or other hormone-sensitive cancer, or those taking aromatase inhibitors — should be made together with your own physician and, where relevant, your oncologist. New or recurrent urinary symptoms, fever, flank pain, or signs of systemic infection warrant prompt medical attention.

Scroll to Top